Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.
about
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersPerspectives on: SGP symposium on mitochondrial physiology and medicine: molecular identities of mitochondrial Ca2+ influx mechanism: updated passwords for accessing mitochondrial Ca2+-linked health and diseaseRoles and functions of HIV-1 Tat protein in the CNS: an overviewReal-time electrochemical recording of dopamine release under optogenetic stimulationTime-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersCurcumin ameliorates hippocampal neuron damage induced by human immunodeficiency virus-1Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations.Effects of HIV-1 Tat on enteric neuropathogenesis.Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disordersHIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND).Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin ASensitization of enteric neurons to morphine by HIV-1 Tat protein.Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.HIV-1 proteins, Tat and gp120, target the developing dopamine systemIntra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in ratsModeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisOligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.HIV, Tat and dopamine transmission.Calpain mediates epithelial cell microvillar effacement by enterohemorrhagic Escherichia coli.Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.The role of human dopamine transporter in NeuroAIDS.Interference with Ca2+-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia.N-acetylcysteine reverses cardiac myocyte dysfunction in HIV-Tat proteinopathy.Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.
P2860
Q26777952-A41DEF69-6AB8-4C07-BF7D-6D8775DCAD61Q26825158-BA32E4A9-3D83-4F8C-B9B6-8B77EA363059Q26996314-FD012B8D-274B-48DB-A754-7747FD8C618EQ28540011-BD012561-3BA4-4541-B80B-3B24E43A3544Q33734695-AF08C3D6-6E02-4162-B49E-D4A213474458Q33937629-7D0EEDE1-41D2-451C-A368-4927B2394D50Q34017924-F019D807-CBD8-43E4-A6D2-5A0ED183A756Q34197724-8B54E7A5-1033-4C14-9504-2CAC8FB3AD47Q34375859-70279950-7631-479B-8898-F2146297A3FCQ34383417-AE447E02-51FF-4E79-9CB7-50C005F66751Q34517239-D77CB53C-D8F4-44D5-BD9D-18A35A2A4440Q34903986-9019D12B-556F-4098-AA3D-53D538BB4CF3Q34939810-8656EF5E-8EFA-4974-8849-DE572A6A0959Q35236345-C2EF9E9B-4062-4F03-8C9B-73D0C91A1EFCQ35606725-388ECA95-76A0-4A6B-A7A6-8658DB9E639AQ35743630-71C52300-A258-475E-A2EB-1135147E72FFQ35757268-780EDE67-3284-441E-9102-D11A79476C35Q35921136-DC9A3A09-543B-438A-A26C-D9279BE0DECBQ35941437-8B8292B7-D9BB-4FCA-A9C2-067A05BF4C25Q36109980-CD0741D4-758E-4179-96D9-F083B2147CA3Q36634476-59101FA5-DCAB-43C2-923D-8356548741AFQ36754429-D8A3D687-05CE-4AE9-9062-586541D5BA9CQ36944251-AF559A93-00DB-4542-9F87-8996859570F4Q36984167-DABE2339-B288-4C47-AE5F-39DF065E68F4Q37597459-4A5B6382-1EED-44F9-B850-7B6E0DAAEC4BQ37672037-5BFAF556-92E6-4AC1-82AB-DEBE0FCEA39FQ38812005-62DC5C06-549F-443F-943E-821673612328Q38979394-8ADC451A-18F9-4B2F-96B9-81389E5A9308Q40112882-4DC62500-5B87-4638-B7FB-63A8CC6B2D36Q41922188-DB285E5D-B843-4883-AB7F-CCAD2496BA2BQ42155053-F486C537-A6AE-407A-8B77-FC1BF8CE092CQ44975297-E47792BD-1AC3-42E7-85CA-A79000A9C928Q47397529-3D8F6FE2-EAE2-49EB-BFC8-43FC9CA4962D
P2860
Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human immunodeficiency virus-1 ...... rter-specific uptake and Vmax.
@ast
Human immunodeficiency virus-1 ...... rter-specific uptake and Vmax.
@en
type
label
Human immunodeficiency virus-1 ...... rter-specific uptake and Vmax.
@ast
Human immunodeficiency virus-1 ...... rter-specific uptake and Vmax.
@en
prefLabel
Human immunodeficiency virus-1 ...... rter-specific uptake and Vmax.
@ast
Human immunodeficiency virus-1 ...... rter-specific uptake and Vmax.
@en
P2093
P2860
P1476
Human immunodeficiency virus-1 ...... orter-specific uptake and Vmax
@en
P2093
Angela Stout
Justin Barbieri
Michelle Kiebala
Oksana Polesskaya
Rebecca Lu
Sanjay B Maggirwar
Santosh Pudasaini
P2860
P304
14153-14164
P356
10.1523/JNEUROSCI.1042-10.2010
P407
P577
2010-10-01T00:00:00Z